Abstract
Aspirin (ASA)-sensitive asthma is characterised by a typical sequence of symptoms, including intense eosinophilic inflammation of nasal and bronchial tissues. It is more commonly found in non-atopic, middle-aged female asthmatic patients with chronic rhino-sinusitis and/or nasal polyps. The lysine-aspirin bronchoprovocation test has become a widely used diagnostic test. When ASA-sensitive asthma is confirmed, complete avoidance of ASA/non-steroidal anti-inflammatory agents (NSAIDs) is crucial in preventing life-threatening adverse reactions. The basic principle of pharmacotherapy is step-wise treatment based upon anti-inflammatory therapy. Corticosteroids are the mainstay of therapy and anti-leukotriene agents may be indicated for treatment of the underlying disease. ASA desensitisation may reduce inflammatory mucosal disease symptoms, particularly in the nasal passage.
Similar content being viewed by others
References
McDonald JR, Mathison DA, Stevenson DD. Aspirin intolerance, detection by oral challenge. J Allergy Clin Immunol 1972; 50: 198–207
Spector SL, Wangaard CH, Farr RS. Aspirin and concomitant idiosyncrasies in adult asthmatic patient. J Allergy Clin Immunol 1979; 64: 500–6
Weber RW, Hoffman M, Raine D. Incidence of bronchoconstriction due to aspirin, azo dyes, non-azo dyes, and preservatives in a population of perennial asthmatics. J Allergy Clin Immunol 1979; 64: 32–7
Delaney JC. The diagnosis of aspirin idiosyncrasy by analgesic challenge. Clin Allergy 1976; 6: 177–81
Park HS, Cho YH, Kim SS, et al. Prevalence of sensitivity to aspirin and food additives in subjects diagnosed as having intrinsic asthma. J Asthma Allergy Clin Immunol 1998; 18: 662–71
Stevenson DD, Lewis R. Proposed mechanisms of aspirin sensitivity reactions. J Allergy Clin Immunol 1987; 80: 788–90
Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin like drugs. Nature 1971; 231: 232–5
Szczeklik A, Stevenson DD. Aspirin-induced asthma: advances in pathogenesis and management. J Allergy Clin Immunol 1999; 104: 5–13
Nizankowska E, Duplaga M, Bochenek G, et al., on behalf of the AIANE project. Clinical course of aspirin-induced asthma: results of AIANE. In: Szczeklik A, Gryglewski RJ, Vane JR, editors. Eicosanoids, aspirin and asthma. New York: Marcel Dekker, Inc, 1998: 451–71
Park HS. Complete resolution of airway hyperresponsiveness to methacholine in aspirin-sensitive asthmatic patients. Korean J Int Med 1996; 11: 157–60
Stevenson DD, Simon RA. Sensitivity to aspirin and non-steroidal anti-inflammatory drugs. In:Middleton E, Reed CE, Ellis EF, et al. Allergy: principle and practice. St Louis (MO): Mosby Company, 1997: 1225
Bianco S, Robuschi M, Petrini G. Aspirin induced tolerance in aspirin-asthma detected by a new challenge test. IRCS J Med Sci 1977; 5: 126–36
Melillo G, Podovano A, Cocco G, et al. Dosimeter inhalation test with lysine acetylsalicylate for the detection of aspirin-induced asthma. Ann Allergy 1993; 71: 61–50
Dahlen B, Zetterstrom O. Comparison of bronchial and per oral provocation with aspirin in aspirin-sensitive asthmatics. Eur Respir J 1990; 3: 527–34
Park HS. Early and late onset asthmatic responses following lysine-aspirin inhalation in aspirin-sensitive asthmatic patients. Clin Exp Allergy 1995; 25: 38–40
Milewski M, Mastalerz L, Nizankowska E, et al. Nasal provocation test for diagnosis of aspirin-induced asthma. J Allergy Clin Immunol 1998; 101: 581–6
Settipane RA, Schrank PJ, Simon RA, et al. Prevalence of cross-sensitivity with acetaminophen in aspirin-sensitive asthmatic subjects. J Allergy Clin Immunol 1995; 96: 480–5
Andri L, Senna G, Betteli C, et al. Tolerability of nimesulide in aspirin-sensitive patients. Ann Allergy Asthma Immunol 1994; 72: 29–32
Kosnik M, Music E, Matjaz F, et al. Relative safety of meloxicam in NSAID-intolerant patients. Allergy 1998; 53: 1231–3
Quaratino D, Romano A, Papa G, et al. Long-term tolerability of nimesulide and acetaminophen in nonsteroidal anti-inflammatory drug-intolerant patients. Ann Allergy Asthma Immunol 1997; 79: 47–50
Park HS, Kim YS, Suh JE, et al. Sodium salicylate sensitivity in an asthmatic patient with aspirin sensitivity. J Korean Med Sci 1991; 6: 113–7
Chudwin DC, Strub M, Golden HE, et al. Sensitivity to non-acetylated salicylates in a patient with asthma, nasal polyps, and rheumatoid arthritis. Ann Allergy 1986; 57: 133–4
Stevenson DD, Simon RA, Lumry WR, et al. Adverse reaction to tartrazine. J Allergy Clin Immunol 1986; 78: 182–91
Goldstein DA, Zimmerman B, Spielberg SP. Anaphylactic response to hydrocortisone in childhood: a case report. Ann Allergy 1985; 55: 599–600
Szczeklik A, Nizankowska E, Czerniawska-Mysik G, et al. Hydrocortisone and airflow impairment in aspirin-induced asthma. J Allergy Clin Immunol 1985; 76: 530–6
Feigenbaum BA, Stevenson DD, Simon RA. Hydrocortisone sodium succinate does not cross-react with aspirin in aspirin-sensitive patients with asthma. J Allergy Clin Immunol 1995; 96: 545–8
National Heart, Lung and Blood Institute, NIH. Expect panel report II: guideline for the diagnosis and management of asthma. Bethesda (MD): National Institute of Health Publishers 1997
Yoshida S, Amayasu H, Sakamoto H, et al. Cromolyn sodium prevents bronchoconstriction and urinary LTE4 excretion in aspirin-induced asthma. Ann Allergy Asthma Immunol 1998; 80: 171–6
Nasser SMS, Bell GS, Foster S, et al. Effect of the 5-lipoxygenase inhibitor ZD2138 on aspirin-induced asthma. Thorax 1994; 49: 749–56
Dahlen B, Margolskee DJ, Zetterström O, et al. Effect of the leukotriene receptor antagonist MK-0679 on baseline pulmonary function in aspirin-sensitive asthmatic subjects. Thorax 1993; 48: 1205–10
Yamamoto H, Nagata M, Kuramitsu K, et al. Inhibition of analgesic-induced asthma by leukotriene receptor antagonist ONO-1078. Am J Respir Crit Care Med 1994; 150: 254–7
Yoshida S, Sakamoto H, Yamawaki Y, et al. Effect of acyclovir on bronchoconstriction and urinary leukotriene E4 excretion in aspirin-induced asthma. J Allergy Clin Immunol 1998; 102: 909–14
Shoji T, Yoshida S, Sakamoto H, et al. Anti-inflammatory effect of roxithromycin in patients with aspirin-intolerant asthma. Clin Exp Allergy 1999; 29: 950–6
McNeil DL. Oral gold therapy in steroid-dependent asthma, nasal polyposis, and aspirin hypersensitivity. Ann Allergy Asthma Immunol 1990; 65: 288–90
Nizankowska E, Soja J, Pinis G, et al. Treatment of steroid-dependent bronchial asthma with cyclosporin. Eur Respir J 1995; 8: 1091–9
Stevenson DD, Pleskow WW, Simon RA, et al. Aspirin-sensitive rhino-sinusitis and asthma: a double blind crossover study of treatment with aspirin. J Allergy Clin Immunol 1984; 73: 500–7
Sweet JA, Stevenson DD, Simon RA, et al. Long-term effects of aspirin desensitization treatment for aspirin sensitive rhino-sinusitis asthma. J Allergy Clin Immunol 1990; 86: 59–65
Stevenson DD, Hankammer MA, Mathison DA, et al. Long-term ASA desensitization-treatment of aspirin sensitive asthmatic patients: clinical outcome studies. J Allergy Clin Immunol 1996; 98: 751–8
Mastalerz L, Milewski M, Duplaga M, et al. Intranasal fluticasone propionate for chronic eosinophilic rhinitis in-patients with aspirin-induced asthma. Allergy 1997; 52: 895–900
Mathison DA, Stevenson DD. Aspirin sensitivity in rhinosinusitis-asthma. In: Lichtenstin LM, Fauci AS, editors. Current therapy in allergy, immunology and rheumatology. Vol. 1. 1st ed. St Louis (MO): Mosby, 1985: 27–30
Schanikin B, May M, Shapiro A, et al. Endoscopic sinus surgery: 4-year follow-up on the first 100 patients. Laryngoscope 1993; 103:1117–20
Kennedy DW. Prognostic factors, outcomes and staging in ethmoid sinus surgery. Laryngoscope 1992; 102: 1–18
Slavin RG. Asthma and sinusitis. J Allergy Clin Immunol 1992; 90: 534–7
Mings R, Friedman WH, Linford PA, et al. Five-year follow-up of the effects of bilateral intranasal sphenoidethmoidectomy in-patients with sinusitis and asthma. Am J Rhinology 1998; 2: 13–6
McFadden EA, Kany RJ, Fink JN. Surgery for sinusitis and aspirin triad. Laryngoscope 1990; 100: 1043–50
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Park, HS. Aspirin-Sensitive Asthma. BioDrugs 13, 29–33 (2000). https://doi.org/10.2165/00063030-200013010-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00063030-200013010-00004